1-6 of 6
Shuhei Yamada
Close
Sort by
Journal Articles

Heparanase-enhanced shedding of syndecan-1 by myeloma cells promotes endothelial invasion and angiogenesis

Anurag Purushothaman, Toru Uyama, Fumi Kobayashi, Shuhei Yamada, Kazuyuki Sugahara, Alan C. Rapraeger, Ralph D. Sanderson
Journal: Blood
Blood (2010) 115 (12): 2449–2457.
https://doi.org/10.1182/blood-2009-07-234757
Published: 2010
Journal Articles

Leukemic Presentation Is Predictive Indicator for Relapse for Patients with Follicular Lymphoma Treated with Rituximab Containing Initial Therapy.

Makoto Kodaira, MD, Kengo Takeuchi, MD, Eriko Nara, Kenji Nakano, MD, Kyoko Ueda, MD, Shuhei Yamada, MD, Yuko Mishima, Masahiro Yokoyama, Yasuhito Terui, MD, PhD, Kiyohiko Hatake, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 4763.
https://doi.org/10.1182/blood.V114.22.4763.4763
Published: 2009
Journal Articles

Dose-Dense Weekly Rituximab and Standard CHOP Therapy in 123 Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma; Ganken Ariake Lymphoma Study Group Analysis.

Masahiro Yokoyama, MD, Yasuhito Terui, MD, PhD, Kengo Takeuchi, MD, Hiroaki Asai, MD, Makoto Kodaira, MD, Kyoko Ueda, MD, Shuhei Yamada, MD, Yuko Mishima, MD, Sakura Sakajiri, MD, Takashi Saotome, MD, Shunji Takahashi, MD, Kiyohiko Hatake, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 3697.
https://doi.org/10.1182/blood.V114.22.3697.3697
Published: 2009
Journal Articles

The Efficacy of R-ICE Therapy as a Salvage Treatment for Relapse and Refractory Diffuse Large B-Cell Lymphoma.

Makoto Kodaira, MD, Masahiro Yokoyama, M.D., Hiroaki Asai, M.D., Shuhei Yamada, M.D., Kyoko Ueda, M.D., Tomohiro Myojo, M.D., Tomoko Nishimura, M.D., Yuko Mishima, M.D., Sakura Sakajiri, M.D., Kengo Takeuchi, M.D., Takashi Saotome, M.D., Yasuhito Terui, M.D. Ph.D., Shunji Takahashi, M.D., Kiyohiko Hatake, M.D. Ph.D.
Journal: Blood
Blood (2007) 110 (11): 4441.
https://doi.org/10.1182/blood.V110.11.4441.4441
Published: 2007
Journal Articles

Addition of Rituximab to CHOP Chemotherapy Does Not Improve Clinical Outcome in Patients with Localized Gastric Diffuse Large B-Cell Lymphoma: A Retrospective Study by Ganken Adult Lymphoma Study Group (Single Institute Analysis).

Masahiro Yokoyama, MD, Daisuke Ennishi, MD, Hiroaki Asai, MD, Kyoko Ueda, MD, Makoto Kodaira, MD, Shuhei Yamada, MD, Tomohiro Myojo, MD, Yuko Mishima, MD, Sakura Sakajiri, MD, PhD, Kengo Takeuchi, MD, PhD, Takashi Saotome, MD, Yasuhito Terui, MD, PhD, Shunji Takahashi, MD, PhD, Yoshinori Ito, MD, PhD, Kiyohiko Hatake, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 4449.
https://doi.org/10.1182/blood.V110.11.4449.4449
Published: 2007
Journal Articles

Addition of Rituximab to CHOP Regimen Improves Clinical Outcome in Non-Germinal Center Type Diffuse Large B-Cell Lymphoma.

Masahiro Yokoyama, MD, Daisuke Ennishi, MD, Kyoko Ueda, MD, Makoto Kodaira, MD, Shuhei Yamada, MD, Tomohiro Myojo, MD, Sakura Sakajiri, MD, Yuko Mishima, MD, Kengo Takeuchi, PHD, Takashi Saotome, MD, Yasuhito Terui, MD, Shunji Takahashi, MD, Yoshinori Ito, MD, Kiyohiko Hatake, MD
Journal: Blood
Blood (2006) 108 (11): 4725.
https://doi.org/10.1182/blood.V108.11.4725.4725
Published: 2006